Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $96,640 - $127,228
-2,401 Reduced 28.41%
6,050 $251,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $27,876 - $31,606
581 Added 7.38%
8,451 $458,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $24,191 - $28,867
-499 Reduced 5.96%
7,870 $403,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $31,665 - $35,407
-547 Reduced 6.14%
8,369 $485,000
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $34,148 - $37,916
-536 Reduced 5.67%
8,916 $570,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $110,129 - $124,912
1,676 Added 21.55%
9,452 $655,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $43,621 - $51,654
637 Added 8.92%
7,776 $560,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $6 - $3,842
-50 Reduced 0.7%
7,139 $507,000
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $96,003 - $105,733
-1,322 Reduced 15.53%
7,189 $554,000
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $100,212 - $120,163
-1,630 Reduced 16.07%
8,511 $622,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $134,825 - $157,175
2,514 Added 32.96%
10,141 $632,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $5,857 - $6,861
99 Added 1.32%
7,627 $451,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $98,003 - $106,725
1,583 Added 26.63%
7,528 $503,000
Q1 2021

May 18, 2021

BUY
$59.34 - $66.74 $22,905 - $25,761
386 Added 6.94%
5,945 $375,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $8,372 - $9,487
145 Added 2.68%
5,559 $345,000
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $46,231 - $51,230
805 Added 17.47%
5,414 $326,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $44,075 - $51,528
804 Added 21.13%
4,609 $271,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $11,553 - $16,790
-249 Reduced 6.14%
3,805 $212,000
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $199,497 - $260,226
4,054 New
4,054 $261,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Visionary Wealth Advisors Portfolio

Follow Visionary Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.